Cytokines are small secreted proteins important in cell signaling. The multi-faceted applications of cytokines in various domains, like prophylactic, diagnostic, and therapeutic use, to cure various diseases has widened the horizons of the cytokine market, globally. Increased acceptance in cancer therapy, potential biomarker in neonatal sepsis, and potential contribution in stem cell therapy.
Cytokines are a group of immune-mediators, which comprise of TNF-superfamily members, such as, interferons, interleukins, and chemokines. Several cytokines and their receptors have been used to treat various diseases that include rheumatoid arthritis (RA), Type I diabetes, and multiple sclerosis (MS).
Latest development
Cytokines IL-1, IL-6, and TNF-α, which appear to play an important role in the progression of rheumatoid arthritis, are also therapeutic targets for the treatment of rheumatoid arthritis.
Market Insights
In 2016, the global cytokine market was valued at USD 40,827 million. Considering the historical trend and possible future developments, the market is projected to reach USD 64,429 million by 2022, registering a CAGR of 7.9% during 2017-2022 (the forecast period).
Get the Full Report Here: Global Cytokine Market
The global cytokine market has been segmented by cytokine type (Tumor Necrosis Factor (TNF), Interleukins (IL), Interferon (IFN), Epidermal Growth Factor (EGF), and therapeutic application (cancer & malignancies, asthma/airway inflammation, arthritis, and others). The report also provides in-depth analysis of the cytokine market in the different geographical locations, namely North America, Europe, Asia-Pacific, the Middle East & Africa, and South America. The segment on North America includes Canada, the United States, and Mexico. The European segment includes the United Kingdom, Germany, France, Italy, Spain, and the Rest of Europe. The Asia-Pacific market segment includes Australia, New Zealand, China, India, Japan, South Korea, and the Rest of Asia-Pacific. The Middle East & Africa (MEA) segment includes GCC, South Africa, and the Rest of MEA. South America includes Brazil, Argentina, and the Rest of South America. The report includes competitive vendor landscape while considering major companies, such as AbbVie, Biotechne, Biocon, Johnson & Johnson, and others.
About Mordor Intelligence
Mordor Intelligence is a market intelligence and business advisory firm. The company operates in the business of industry analysis & consulting, in over 16 verticals. In today’s fast-paced and competitive business environment, every customer has unique information requirements. With an eye to such requirements, Mordor offers custom market intelligence and advisory services along with syndicated reports, to help them gain an edge over the competition. The company has successfully catered to over 500 (40% of whom are Fortune 500) clients, since 2013.
For more information mail us at: https://www.mordorintelligence.com/